Key points are not available for this paper at this time.
Despite some early doubts concerning its presence in plasma and its physiological function (1-4), the thyroxine-binding prealbumin of human serum (TBPA) is now known to play a significant role in the transport of thyroxine (T4) (5-8). Nor- mally, as assessed by in vitro techniques, TBPA appears to bind at least 25 to 35%o of T4 in serum (5, 6). In the serum of many patients with se- vere acute or chronic illness, however, the propor- tion of endogenous T4 in serum bound by TBPA and the T4-binding capacity of TBPA decline The recent availability of substantial quanti- ties of a highly purified preparation of TBPA has made possible an investigation of the in vivo me- tabolism of this protein in normal patients and in patients with a variety of disorders that lead to de- creased binding of T4 by TBPA in serum. In ad- dition, the cause of this decrease in T4 binding in the serum of such "sick" patients has been evalu- ated. A portion of the findings has been presented in abstract form While these studies were in progress, Oppenheimer, Surks, Bernstein, and Smith reported similar studies in abstract form (11, 12).
Building similarity graph...
Analyzing shared references across papers
Loading...
EDWARD L. SOCOLOW
Kenneth A. Woeber
Robert H. Purdy
Journal of Clinical Investigation
Harvard University
Building similarity graph...
Analyzing shared references across papers
Loading...
SOCOLOW et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69dbc38f387cf70698688a57 — DOI: https://doi.org/10.1172/jci105266